Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Zurich
IRCCS San Raffaele
Fondazione Italiana Linfomi - ETS
University Hospital, Bordeaux
Fujian Medical University
AstraZeneca
Novartis
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Max-Planck-Institute of Psychiatry
Ruijin Hospital
Celgene
Celgene
Pfizer
Seoul St. Mary's Hospital
Mustang Bio
Gruppo Italiano Malattie EMatologiche dell'Adulto
Celgene
AbbVie
Regeneron Pharmaceuticals
University of California, San Francisco
Samsung Medical Center
Rutgers, The State University of New Jersey
University of Aarhus
Hospital General de Mexico
Takeda
Federico II University
Fondazione Italiana Linfomi - ETS
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Multinational Center for Quality of Life Research, Russia
Mayo Clinic
Curewize Health Ltd.
Vanderbilt-Ingram Cancer Center
National Institutes of Health Clinical Center (CC)
Samsung Medical Center
Vanderbilt University Medical Center
Celgene
A.O.U. Città della Salute e della Scienza
Astellas Pharma Inc
Hoffmann-La Roche
Duke University
Hospices Civils de Lyon
Columbia University
Mayo Clinic
Children's Oncology Group
Children's Oncology Group
Vanderbilt-Ingram Cancer Center
Samsung Medical Center
Case Comprehensive Cancer Center